UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

Annals of oncology, 2017-11, Vol.28 (suppl_8), p.viii8-viii12

2017

Volltextzugriff (PDF)

When prospective randomised trials have unexpected results: where do we go from there?

BJOG : an international journal of obstetrics and gynaecology, 2019-07, Vol.126 (8), p.960-960

Duska, LR

2019

Volltextzugriff (PDF)

Surgery is critical to a multidisciplinary approach to ovarian cancer

BJOG : an international journal of obstetrics and gynaecology, 2018-09, Vol.125 (10), p.1253-1253

Duska, LR

2018

Volltextzugriff (PDF)

Recognising endometrial cancer in pre‐menopausal women

BJOG : an international journal of obstetrics and gynaecology, 2017-02, Vol.124 (3), p.412-412

Duska, LR

2017

Volltextzugriff (PDF)

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

BJOG : an international journal of obstetrics and gynaecology, 2020-05, Vol.127 (6), p.737-737

2020

Volltextzugriff (PDF)

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

BJOG : an international journal of obstetrics and gynaecology, 2017-01, Vol.124 (1), p.149-149

Duska, LR

2017

Volltextzugriff (PDF)

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Gynecologic oncology, 2022-07, Vol.166 (1), p.44-49

2022

Volltextzugriff (PDF)

PET trumps surgical staging in locally advanced cervical cancer

BJOG : an international journal of obstetrics and gynaecology, 2017-06, Vol.124 (7), p.1095-1095

2017

Volltextzugriff (PDF)

A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Gynecologic oncology, 2020-06, Vol.157 (3), p.585-592

2020

Volltextzugriff (PDF)

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Gynecologic oncology, 2021-03, Vol.160 (3), p.688-695

2021

Volltextzugriff (PDF)

At the end of life: Optimizing quality of care for women dying of cervical cancer

Gynecologic oncology, 2013-07, Vol.130 (1), p.e141-e141

Duska, L

2013

Volltextzugriff (PDF)

The role of imaging in the initial evaluation of cervical cancer

Gynecologic oncology, 2017-06, Vol.145, p.177-178

2017

Volltextzugriff (PDF)

Risk factors for surgical site infection after ovarian cancer debulking: An ACS NSQIP analysis

Gynecologic oncology, 2017-06, Vol.145, p.141-141

2017

Volltextzugriff (PDF)

Cancer-related fertility education in women at a public rural institution

Gynecologic oncology, 2015-04, Vol.137, p.149-149

2015

Volltextzugriff (PDF)

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Gynecologic oncology, 2017-11, Vol.147 (2), p.276-282

2017

Volltextzugriff (PDF)

Are women with gynecologic malignancies at risk for opioid misuse?

Gynecologic oncology, 2017-06, Vol.145, p.46-46

2017

Volltextzugriff (PDF)

Levonorgestrel intrauterine device (IUD) treatment of complex atypical hyperplasia and grade 1 endometrioid endometrial cancer in postmenopausal women

Gynecologic oncology, 2014-06, Vol.133, p.158-158

2014

Volltextzugriff (PDF)

Preoperative imaging of uterine malignancy

Gynecologic oncology, 2014-06, Vol.133, p.144-145

2014

Volltextzugriff (PDF)

Obesity does not influence the decision between neoadjuvant chemotherapy and upfront cytoreductive surgery in advanced ovarian cancer

Gynecologic oncology, 2016-06, Vol.141, p.100-101

2016

Volltextzugriff (PDF)

HPV vaccination of adolescents in a dedicated refugee clinic

Gynecologic oncology, 2017-06, Vol.145, p.185-186

2017

Volltextzugriff (PDF)

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Annals of oncology, 2018-10, Vol.29, p.viii404-viii405

2018

Volltextzugriff (PDF)

Does frequency of laboratory testing impact clinically important outcomes in patients undergoing platinum-based chemotherapy?

Gynecologic oncology, 2016-06, Vol.141, p.41-41

2016

Volltextzugriff (PDF)

Abstract 1: Gynecologic oncologists as benign gynecologic surgeons

Gynecologic oncology, 2015-06, Vol.137 (3), p.591-591

2015

Volltextzugriff (PDF)

Cervical cancer care in rural America: The impact of distance on outcomes and the role of nonspecialized radiation centers

Gynecologic oncology, 2016-06, Vol.141, p.199-199

2016

Volltextzugriff (PDF)

Who is referred to the gynecologic oncology clinic with an adnexal mass?

Gynecologic oncology, 2016-06, Vol.141, p.139-139

2016

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(149)
Humans
(128)
Female
(102)
Oncology
(76)
Obstetrics & Gynecology
(64)
Middle Aged
(60)
Adult
(53)
Biological And Medical Sciences
(52)
Hematology, Oncology And Palliative Medicine
(50)
Obstetrics And Gynecology
(50)
Medical Sciences
(49)
Aged
(46)
Tumors
(31)
Animals
(30)
Male
(27)
Aged, 80 And Over
(26)
Retrospective Studies
(24)
Ovarian Cancer
(23)
Ovarian Neoplasms - Drug Therapy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

When prospective randomised trials have unexpected results: where do we go from there?

Surgery is critical to a multidisciplinary approach to ovarian cancer

Recognising endometrial cancer in pre‐menopausal women

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

PET trumps surgical staging in locally advanced cervical cancer

A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

At the end of life: Optimizing quality of care for women dying of cervical cancer

The role of imaging in the initial evaluation of cervical cancer

Risk factors for surgical site infection after ovarian cancer debulking: An ACS NSQIP analysis

Cancer-related fertility education in women at a public rural institution

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Are women with gynecologic malignancies at risk for opioid misuse?

Levonorgestrel intrauterine device (IUD) treatment of complex atypical hyperplasia and grade 1 endometrioid endometrial cancer in postmenopausal women

Preoperative imaging of uterine malignancy

Obesity does not influence the decision between neoadjuvant chemotherapy and upfront cytoreductive surgery in advanced ovarian cancer

HPV vaccination of adolescents in a dedicated refugee clinic

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Does frequency of laboratory testing impact clinically important outcomes in patients undergoing platinum-based chemotherapy?

Abstract 1: Gynecologic oncologists as benign gynecologic surgeons

Cervical cancer care in rural America: The impact of distance on outcomes and the role of nonspecialized radiation centers

Who is referred to the gynecologic oncology clinic with an adnexal mass?

Suchergebnisse filtern